Trial Profile
A Phase 1 Study of Quercetin in Patients With Hepatitis C
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Quercetin (Primary)
- Indications Hepatitis C
- Focus Adverse reactions
- 24 Sep 2011 New trial record